CNJ-016
NDC 60492-0173, Vaccinia Immune Globulin Intravenous (Human), injection, from Emergent BioSolutions Canada Inc..
- Product NDC
- 60492-0173
- Status
- Listed
- Labeler
- Emergent BioSolutions Canada Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125109
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60492-0173 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HUMAN VACCINIA VIRUS IMMUNE GLOBULIN1 [iU]/mL
Pharmacologic classes
Human Immunoglobulin G [EPC]; Immunoglobulins [CS]; Passively Acquired Immunity [PE]; Virus Neutralization [MoA]; Virus-specific Hyperimmune Globulins [EXT]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60492-0173-2 | 60492017302 | 24 VIAL, SINGLE-USE in 1 CARTON (60492-0173-2) / 12 mL in 1 VIAL, SINGLE-USE (60492-0173-1) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/a4f9f620-e6e4-4a03-a9a7-79007c8c2cfe
Use it
Look up 60492-0173 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60492-0173 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60492-0173. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.